ISREC Foundation

Founded on June 18th 1964, the ISREC Foundation is a private non-profit foundation.

The Foundation started its activity with the creation of the Swiss Institute for experimental cancer research. Today its mission is to select and support translational cancer research projects and so to help the transfer of knowledge and collaboration between fundamental research and clinical research. The goal of these innovative projects is to translate discoveries into results and to have a positive impact on the future treatment of human cancer.
In this context, the ISREC Foundation is investing in a large-scale project, the AGORA Cancer Center, which will be built near the CHUV university hospital in Lausanne. This Center will host researchers and clinicians from the UNIL, the EPFL, the LICR and other institutions. Devoted to translational cancer research, it will make it possible to intensify exchanges between researchers and clinicians and to find solutions to the multiple challenges presented by this disease. It will also reinforce the synergies and benefit from manifold competences and thus establish a unique center in Switzerland that will host up to two hundred researchers.
The ISREC Foundation also undertakes to support scientific training as well as projects that encourage the scientific and academic future in cancer research, in particular the projects of PhD students in biology or medicine taking part in doctoral programs.

The Swiss institute for experimental cancer research was supported over several decades by the ISREC Foundation. Since 2008, it is financed by the EPFL and integrated into its School of Life Sciences. The new Director is Professor Douglas Hanahan. Prominent amongst the Institute’s research topics are the signaling pathways that normally regulate aspects of embryogenesis and organogenesis along with the mechanisms orchestrating cell division and the maintenance of genomic integrity during cell proliferation. For more information: http://isrec.epfl.ch.